Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BDSX · against 261 other Healthcare companies of similar size
Ranked #167 of 262 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score96 peers with a valuation score of 0–9, including BDSX · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | BDSX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 245 reported | -15.5% | -1.0% | 31% | 30% | |
| EBITDA yieldHigher is better · 268 reported | -5.7% | 1.4% | 34% | 50% | |
| Free cash flow yieldHigher is better · 143 reported | -9.2% | -12.2% | 56% | 20% | |
| Book yieldHigher is better · 250 reported | 4.1% | 61.3% | 10% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 167 | 271M USD | 8 | 14 | |
| 167 | 115M USD | 8 | 8 | |
| 167 | 377M USD | 8 | 29 | |
| 167 | 334M USD | 8 | 36 | |
| 167 | 222M USD | 8 | 31 | |
| 167 | 293M USD | 8 | ||
| 167 | 241M USD | 8 | ||
| 167 | 393M USD | 8 | 50 | |
| 167 | 395M USD | 8 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score